nav.banner_textnav.banner_cta
CJC-1295 w/o DAC research vial
SwissNova Labs
CJC-1295 w/o DAC · 5mg
≥99% Purity · COA Included
Growth Hormone

CJC-1295 w/o DAC

Purity: 99%+
Size: 5mg
Grade: Research
Form: Lyophilized
SwissNova Labs · Research Grade
Growth HormoneNEW!

CJC-1295 w/o DAC

Short-acting GHRH analog for pulsatile GH release — ideal with Ipamorelin.

Pulsatile GH release — short half-life produces physiological GH spikesSynergistic stacking — combines with Ipamorelin for 10× GH amplificationNo receptor desensitization — pulsatile pattern preserves long-term pituitary responsivenessBody composition — elevated GH supports lean mass and fat reduction
$28.00
5mg · Research use only
Compound Specifications
Purity99%+
Molecular Weight3367.9 Da
Vial Size5mg
SequenceTyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
Dosage Reference
Range100–200 mcg
Frequency1–3× daily (pre-sleep, pre-workout, AM fasted)
RouteSubcutaneous injection
Half-life~30 minutes
Vial Supply
Duration~8 weeks supply
Week 1Week 8

200 mcg twice daily

Why Researchers Choose This Compound

Key Benefits

01
Pulsatile GH release

short half-life produces physiological GH spikes

02
Synergistic stacking

combines with Ipamorelin for 10× GH amplification

03
No receptor desensitization

pulsatile pattern preserves long-term pituitary responsiveness

04
Body composition

elevated GH supports lean mass and fat reduction

Administration Guide

Recommended Injection Sites

Optimal injection locations for CJC-1295 w/o DAC based on its route (Subcutaneous injection) and pharmacokinetic profile.

Tap a glowing zone on the body map to highlight the matching site card — or tap a card to activate the zone.

Site Map — front

Tap a zone to inject

Best
Good
Acceptable
Primary Sites
Abdomen
Best
Periumbilical fat

Preferred for GHRH analogs.

Secondary Sites
Thigh
Good
Anterolateral mid-thigh

Good alternative.

Needle Specs
Gauge27–29 gauge
Length5/16" – 1/2"
Angle45–90°
Site Rotation

Rotate sites each injection.

Avoid
  • IV administration
  • Intramuscular injection
Mechanism of Action

Active Signaling Pathway

Synergistic Protocols

Recommended Stacks

CJC-1295 w/o DAC is a key compound in these curated research stacks. Pair it with synergistic peptides for enhanced outcomes.

Fitness & Performance

GH Pulse Amplifier

The gold-standard two-signal GH stack — GHRH + GHRP for maximum physiological GH output.

NEW!
CJC-1295 w/o DACPrimary — GHRH signal (Signal 1)
Provides the GHRH receptor activation signal that primes pituitary somatotrophs for GH release. Short half-life (~30 min) preserves pulsatile pattern.
8–12 weeksBeginner3 compounds
View Full Stack →
Supply Calculator

How long will one vial last?

Based on standard research protocols, here's exactly what to expect from a single 5mg vial — and when to plan your next order.

One vial lasts
8
weeks
That's approximately 2 months of continuous use at the standard protocol dose.
Reorder around week 7 to avoid running out
Your supply timeline5mg vial
Start↑ ReorderWeek 8 — empty
1
2
3
4
5
6
7
8
Active supplyReorder week
How we calculated this
5mg vial ÷ 200 mcg twice daily = 8 weeks of supply

Actual duration may vary based on your specific protocol. Always consult your research guidelines for precise dosing schedules.

Research Literature

Scientific Background

Mechanism of Action

CJC-1295 w/o DAC binds GHRH receptors on pituitary somatotrophs and triggers cAMP-mediated GH synthesis and release. Its short half-life produces discrete GH pulses rather than continuous elevation, preserving the natural pulsatile GH pattern and avoiding receptor desensitization.

Clinical Context

The CJC-1295 w/o DAC + Ipamorelin combination is one of the most studied peptide stacks in GH research. The two-signal mechanism (GHRH + GHRP) closely mimics the physiological GH release pattern.

Research Highlights

  • Produces GH pulses 2–10× above baseline when combined with Ipamorelin
  • Short half-life preserves natural GH pulsatility — reduces risk of receptor downregulation
  • Synergistic with GHRPs: GHRH + GHRP combination produces 10× more GH than either alone
  • Well-characterized pharmacokinetics from multiple preclinical and clinical studies

Storage & Reconstitution

Store at -20°C. Reconstitute with 2 mL bacteriostatic water → 2.5 mg/mL. Stable 30 days at 2–8°C.

PROTOCOL NOTE

Best combined with Ipamorelin 100–200 mcg in the same injection. Typical cycle: 8–12 weeks.

RESEARCH USE ONLY:All products are sold strictly for in vitro research and laboratory use. Not intended for human consumption, clinical use, diagnosis, treatment, or prevention of any disease or condition. By purchasing, you confirm you are a qualified researcher and will use these compounds in accordance with all applicable laws and regulations.